{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T05:12:08Z","timestamp":1791695528051,"version":"4.3.4"},"reference-count":153,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015822","name":"Fondazione Roma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"name":"\u00a0NIH\u00a0","award":["R01EY030851"],"award-info":[{"award-number":["R01EY030851"]}]},{"name":"NSF DMS","award":["1853222\/2021192"],"award-info":[{"award-number":["1853222\/2021192"]}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness, NY","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Annals of Medicine"],"published-print":{"date-parts":[[2022,12,31]]},"DOI":"10.1080\/07853890.2021.1955146","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T10:26:24Z","timestamp":1643106384000},"page":"343-358","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":60,"title":["Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medications"],"prefix":"10.1080","volume":"54","author":[{"given":"Aditya","family":"Belamkar","sequence":"first","affiliation":[{"name":"Indiana University School of Medicine","place":["Indianapolis, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Harris","sequence":"additional","affiliation":[{"name":"Department of Opthalmology, Icahn School of Medicine at Mount Sinai","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Zukerman","sequence":"additional","affiliation":[{"name":"Department of Opthalmology, Icahn School of Medicine at Mount Sinai","place":["New York, USA"]},{"name":"Department of Opthalmology, University of Miami Miller School of Medicine","place":["Miami, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Siesky","sequence":"additional","affiliation":[{"name":"Department of Opthalmology, Icahn School of Medicine at Mount Sinai","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Oddone","sequence":"additional","affiliation":[{"name":"IRCCS, Fondazione Bietti","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Verticchio Vercellin","sequence":"additional","affiliation":[{"name":"Department of Opthalmology, Icahn School of Medicine at Mount Sinai","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5557-6777","authenticated-orcid":false,"given":"Thomas A.","family":"Ciulla","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine","place":["Indianapolis, USA"]},{"name":"Vitreoretinal Medicine and Surgery, Midwest Eye Institute","place":["Indianapolis, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,1,25]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3192"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.05.013"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e31829d9bb0"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.6.701"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.1.48"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7376"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2010.01943.x"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.03-0077"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.01.034"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-307223"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000001106"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.08.010"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305780"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-307570"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000001421"},{"issue":"7","key":"e_1_3_4_17_1","first-page":"1057","article-title":"Trans-lamina cribrosa pressure difference correlated with neuroretinal rim area in glaucoma, Graefe\u2019s Arch","volume":"249","author":"Ren R","year":"2011","unstructured":"Ren R, Wang N, Zhang X, et al. Trans-lamina cribrosa pressure difference correlated with neuroretinal rim area in glaucoma, Graefe\u2019s Arch. Clin Exp Ophthalmol. 2011;249(7):1057\u20131063.","journal-title":"Clin Exp Ophthalmol"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137909"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148412"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150260"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.3109\/08820538.2015.1114855"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102535"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14397"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1350-9462(98)00037-8"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000000520"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12354"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000419"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2012.02778.x"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000000137"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-012-0001-0"},{"issue":"1","key":"e_1_3_4_31_1","first-page":"S20","article-title":"Current management of glaucoma and the need for complete therapy","volume":"4","author":"McKinnon SJ","year":"2008","unstructured":"McKinnon SJ, Goldberg LD, Peeples P, et al. Current management of glaucoma and the need for complete therapy. Am J Manag Care. 2008;4(1 Suppl):S20\u2013S27.","journal-title":"Am J Manag Care"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2016.07.013"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/62.7.691"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.10.1.109"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(96)30749-5"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)00584-X"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(01)01177-1"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(01)00219-3"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(96)30750-1"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200312000-00003"},{"key":"e_1_3_4_41_1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ajo.2003.10.034","article-title":"Persistency with latanoprost or timolol in primary open-angle glaucoma suspects","volume":"137","author":"Schwartz GF","year":"2004","unstructured":"Schwartz GF, Reardon G, Mozaffari E. Persistency with latanoprost or timolol in primary open-angle glaucoma suspects. Am J Ophthalmol. 2004;137(Suppl):S3\u2013S12.","journal-title":"Am J Ophthalmol"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.04.051"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079903125001820"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.12.035"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0290"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.03.026"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-011-9468-2"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S23780"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.05.026"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.09.004"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2010.02050.x"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.5301\/EJO.2010.6112"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.05.013"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.06.012"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.06.024"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e3181f3eb4a"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.2000.03288.x"},{"issue":"3","key":"e_1_3_4_58_1","first-page":"264","article-title":"Determination of tear volume and tear flow","volume":"5","author":"Mishima S","year":"1966","unstructured":"Mishima S, Gasset A, Klyce SD, et al. Determination of tear volume and tear flow. Invest Ophthalmol. 1966;5(3):264\u2013276.","journal-title":"Invest Ophthalmol"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600620712"},{"key":"e_1_3_4_60_1","first-page":"59","article-title":"Precorneal, corneal, and postcorneal factors","volume":"58","author":"Lee V.","year":"1993","unstructured":"Lee V. Precorneal, corneal, and postcorneal factors. Drugs Pharm Sci. 1993;58:59\u201381.","journal-title":"Drugs Pharm Sci"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1980.01020030114010"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.5.5.567"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.3109\/10717544.2014.923065"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600680606"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1177\/2515841420905740"},{"key":"e_1_3_4_66_1","first-page":"27","article-title":"Review of glaucoma drug delivery systems","volume":"24","author":"Wu T","year":"2020","unstructured":"Wu T, Sheybani A. Review of glaucoma drug delivery systems. Ophthalmol Manag. 2020;24:27\u201328.","journal-title":"Ophthalmol Manag"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-020-00769-8"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01248-0"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2016.11.020"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.06.018"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/vop.12522"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2018.0095"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2018.0067"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.04.026"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.04.022"},{"key":"e_1_3_4_76_1","first-page":"1231","article-title":"Patient-reported outcomes of bimatoprost ocular ring in an open-label extension study in patients with open-angle glaucoma or ocular hypertension, Invest. Ophthalmol","volume":"59","author":"Chen MY","year":"2018","unstructured":"Chen MY, Sall KN, Tepedino M, et al. Patient-reported outcomes of bimatoprost ocular ring in an open-label extension study in patients with open-angle glaucoma or ocular hypertension, Invest. Ophthalmol. Vis Sci. 2018;59:1231.","journal-title":"Vis Sci"},{"key":"e_1_3_4_77_1","unstructured":"Glaukos Corporation Glaukos\u2019 iDose\u00ae TR Demonstrates Sustained IOP Reduction and Favorable Safety Profile Over 24 Months in Phase 2b Study Press Releases. 2021."},{"key":"e_1_3_4_78_1","unstructured":"Glaukos Corporation. Glaukos Corporation\u2019s iDoseTM Travoprost achieves sustained IOP reduction and favorable safety profile in 12-Month Interim Cohort. Press Releases. 2018."},{"key":"e_1_3_4_79_1","unstructured":"NCT02371746 Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma https:\/\/Clinicaltrials.Gov\/Show\/NCT02371746. 2015."},{"key":"e_1_3_4_80_1","first-page":"5706","article-title":"Advancing ENV515 (travoprost) intracameral implant into clinical development: nonclinical evaluation of ENV515 in support of first-time-in-human phase 2a clinical study","volume":"56","author":"Navratil T","year":"2015","unstructured":"Navratil T, Garcia A, Verhoeven RS, et al. Advancing ENV515 (travoprost) intracameral implant into clinical development: nonclinical evaluation of ENV515 in support of first-time-in-human phase 2a clinical study. Invest Ophthalmol Vis Sci. 2015;56:5706.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_4_81_1","first-page":"3548","article-title":"Preclinical evaluation of ENV515 (travoprost) intracameral implant \u2013 clinical candidate for treatment of Glaucoma targeting six-month duration of action","volume":"55","author":"Navratil T","year":"2014","unstructured":"Navratil T, Garcia A, Tully J, et al. Preclinical evaluation of ENV515 (travoprost) intracameral implant \u2013 clinical candidate for treatment of Glaucoma targeting six-month duration of action. Invest Ophthalmol Vis Sci. 2014;55:3548.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100901"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S102181"},{"key":"e_1_3_4_84_1","first-page":"3488","article-title":"Evaluation of the safety and efficacy of OTX-TP, an intracanalicular travoprost insert, for the treatment of patients with open-angle glaucoma or ocular hypertension: a phase 3 study","volume":"61","author":"Vantipalli S","year":"2020","unstructured":"Vantipalli S, Sall KN, Stein E, et al. Evaluation of the safety and efficacy of OTX-TP, an intracanalicular travoprost insert, for the treatment of patients with open-angle glaucoma or ocular hypertension: a phase 3 study. Invest Ophthalmol Vis Sci. 2020;61:3488.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_4_85_1","first-page":"5675","article-title":"Improving retention rates for sustained therapeutic delivery through punctal plugs","volume":"59","author":"Utkhede D","year":"2018","unstructured":"Utkhede D, William R. Improving retention rates for sustained therapeutic delivery through punctal plugs. Invest Ophthalmol Vis Sci. 2018;59:5675.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_4_86_1","first-page":"5095","article-title":"2 study evaluating safety and efficacy of the Latanoprost Punctal Plug Delivery System (L-PPDS) in subjects with Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG)","volume":"53","author":"Goldberg DF","year":"2012","unstructured":"Goldberg DF, Williams R, Phase A. 2 study evaluating safety and efficacy of the Latanoprost Punctal Plug Delivery System (L-PPDS) in subjects with Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG). Invest Ophthalmol Vis Sci. 2012;53:5095.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2010.01.113"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1021\/ie000596z"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2011.630154"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.06.038"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2012.10.010"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-020-1622-6"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2018.11.036"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2019.05.025"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1021\/nn5002968"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.09.029"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.0c12667"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2011.10.076"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.05.059"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2013.11.016"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.3129\/i10-090"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1021\/js980222j"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-011-0070-9"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105648"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.3390\/polym11081371"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1166\/jbn.2018.2477"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2008.12.018"},{"key":"e_1_3_4_108_1","first-page":"1296","article-title":"Biodegradable sustained-release drug delivery systems fabricated using a dissolvable hydrogel template technology for the treatment of ocular indications","volume":"56","author":"Malavia N","year":"2015","unstructured":"Malavia N, Reddy L, Szinai I, et al. Biodegradable sustained-release drug delivery systems fabricated using a dissolvable hydrogel template technology for the treatment of ocular indications. Invest Ophthalmol Vis Sci. 2015;56:1296.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2017.11.090"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2020.111383"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1038\/pj.2017.39"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1080\/02652040802095250"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09379-8"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.02.041"},{"issue":"1","key":"e_1_3_4_115_1","first-page":"50","article-title":"A safe GDNF and GDNF\/BDNF controlled delivery system improves migration in human retinal pigment epithelial cells and survival in retinal ganglion cells: potential usefulness in degenerative retinal pathologies","volume":"14","author":"Arranz-Romera A","year":"2021","unstructured":"Arranz-Romera A, Hernandez M, Checa-Casalengua P, et al. A safe GDNF and GDNF\/BDNF controlled delivery system improves migration in human retinal pigment epithelial cells and survival in retinal ganglion cells: potential usefulness in degenerative retinal pathologies. Pharm. 2021;14(1):50.","journal-title":"Pharm"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12080706"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2020.04.055"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsbiomaterials.7b00319"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1080\/10837450.2017.1328693"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.6b16509"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2018.11.017"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2019.11.038"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(00)00103-4"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.08.004"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-017-0710-8"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1316249"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092830"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.04.059"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12040306"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1431927619000448"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612826666200218101231"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.3109\/1061186X.2014.939983"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2019.04.048"},{"key":"e_1_3_4_134_1","first-page":"9445","volume-title":"ACS Appl Mater Interfaces","author":"Schnichels SA-O","year":"2021","unstructured":"Schnichels SA-O, Hurst J, de Vries JW, et al. Interfaces, Improved treatment options for glaucoma with brimonidine-loaded lipid DNA nanoparticles. ACS Appl Mater Interfaces. 2021;13(8):9445\u20139456."},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S25468"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-014-0196-9"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-015-0382-1"},{"key":"e_1_3_4_138_1","first-page":"1","article-title":"Sustained timolol maleate delivery from liposomes for glaucoma therapy and ocular hypertension","volume":"2017","author":"B.Y.C.F","year":"2017","unstructured":"B.Y.C.F, Venkatraman S, Natarajan JV. Sustained timolol maleate delivery from liposomes for glaucoma therapy and ocular hypertension. Google Patents. 2017;2017:1\u201322.","journal-title":"Google Patents"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.12.015"},{"key":"e_1_3_4_140_1","unstructured":"Virno MM. Ophthalmic formulation comprising citicoline carried by liposome for the treatment of glaucoma. Google Patents. 2020."},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2019.04.036"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.105748"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10040197"},{"key":"e_1_3_4_144_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40005-019-00427-1"},{"key":"e_1_3_4_145_1","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2020.1755305"},{"key":"e_1_3_4_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2020.102260"},{"key":"e_1_3_4_147_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2017.11.046"},{"key":"e_1_3_4_148_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24162929"},{"key":"e_1_3_4_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2019.01.004"},{"key":"e_1_3_4_150_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-03834-2"},{"key":"e_1_3_4_151_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2020.111355"},{"key":"e_1_3_4_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100841"},{"key":"e_1_3_4_153_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164876"},{"key":"e_1_3_4_154_1","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200004000-00002"}],"container-title":["Annals of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/07853890.2021.1955146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T09:49:52Z","timestamp":1757324992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/07853890.2021.1955146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":153,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12,31]]}},"alternative-id":["10.1080\/07853890.2021.1955146"],"URL":"https:\/\/doi.org\/10.1080\/07853890.2021.1955146","relation":{},"ISSN":["0785-3890","1365-2060"],"issn-type":[{"value":"0785-3890","type":"print"},{"value":"1365-2060","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iann20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iann20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-05-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}